Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

9.8K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.8K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

352
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
352
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

245
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
245
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

218
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
218
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the potential efficacy of Ziziphus spina-christi on restoring steroid sensitivity in severe asthma.

Fitoterapia·2026
Same author

Microbial dysbiosis and inferred functional profiling reveals the potential role of <i>Methylobacterium</i> in prostate cancer.

Frontiers in cellular and infection microbiology·2026
Same author

The Role of Fecal Microbiome Transplantation in Steroid Hyporesponsive Asthma.

Comprehensive Physiology·2026
Same author

Comprehensive <i>BRCA1/2</i> mutation landscape in prostate cancer in the UAE and Arab population.

Frontiers in cell and developmental biology·2026
Same author

Dupilumab attenuate IL-4 and IL-13 synergistic effect on airway remodeling in asthma via blocking IL-4Rα/STAT6 axis.

Scientific reports·2026
Same author

Systemic flavonoid exposure and NF-κB mediated suppression of Th2 responses by Ziziphus spina-christi attenuate HDM-induced allergic asthma.

Journal of ethnopharmacology·2026
Same journal

MRC2 Links Collagen Turnover to Integrin/PI3K/AKT-Driven Fibrogenesis.

Advanced biology·2026
Same journal

Integrative Database-Driven In Silico and In Vitro Study of Anemarrhena asphodeloides Bunge Highlighting Hippeastrine as a Regulator of the HSP90/PI3K/Akt/mTOR Axis in Oral Squamous Cell Carcinoma.

Advanced biology·2026
Same journal

miR-210 in Ischemic Cardiovascular Disease: Functions, Mechanisms, and Therapeutic Potential.

Advanced biology·2026
Same journal

From Spider Webs to Brains: Can the Bri2 BRICHOS Molecular Chaperone Domain Transport Biological Drugs Into the Central Nervous System?

Advanced biology·2026
Same journal

RNAi-Loaded Exosomes for the Management of Breast Cancer: Emerging Paradigms in Precision Therapy.

Advanced biology·2026
Same journal

Cross-Species Transmission and Structural Adaptive Evolution: Implications of the FCoV-23 Pandemic for the Evolution of Coronaviruses.

Advanced biology·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2025

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

12.7K

Inhibiting DNA Sensing Pathway Controls Steroid Hyporesponsive Lung Inflammation.

Bushra Mdkhana1, Narjes Saheb Sharif-Askari1,2, Roberta Cagliani1,3

  • 1Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, United Arab Emirates.

Advanced Biology
|November 27, 2024
PubMed
Summary
This summary is machine-generated.

DNA damage activates the STING pathway in severe asthma, causing steroid resistance. STING inhibitors, especially when encapsulated in nanoparticles, restore steroid sensitivity and reduce airway inflammation.

Keywords:
PLGA nanoparticlesSTINGnucleic acid sensingsevere asthmasteroid hyporesponsiveness

More Related Videos

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.1K
Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
12:04

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Published on: August 14, 2012

28.8K

Related Experiment Videos

Last Updated: Jun 6, 2025

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
10:51

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

12.7K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.1K
Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
12:04

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy

Published on: August 14, 2012

28.8K

Area of Science:

  • Immunology
  • Pulmonology
  • Molecular Biology

Background:

  • Severe asthma is linked to DNA damage and steroid hyporesponsiveness.
  • Cytosolic DNA sensing, particularly the STING pathway, is implicated but not fully understood in this context.

Purpose of the Study:

  • To investigate the role of the Stimulator of Interferon Genes (STING) pathway in severe asthma and steroid hyporesponsiveness.
  • To evaluate the therapeutic potential of STING inhibitors, including nanoparticle delivery, in a mouse model of steroid-resistant asthma.

Main Methods:

  • Assessed STING levels in human bronchial fibroblasts and mouse lung homogenates.
  • Stimulated cells and tissues with house dust mites (HDM) and treated with dexamethasone and/or STING inhibitors.
  • Examined the impact of STING inhibition on glucocorticoid receptor (GR)-α/GR-β ratio and airway hyperresponsiveness.

Main Results:

  • Elevated STING/IFN-I pathway activation was observed in severe asthmatic fibroblasts and steroid-hyporesponsive mouse lungs, exacerbated by HDM.
  • Dexamethasone alone did not resolve STING activity; combination with a STING inhibitor was effective.
  • STING inhibition restored steroid sensitivity by increasing the GRα/GRβ ratio.
  • Nanoparticle-encapsulated STING inhibitors showed superior efficacy in reducing airway hyperresponsiveness and restoring steroid sensitivity.

Conclusions:

  • STING pathway activation is a key driver of severe asthma pathogenesis and steroid hyporesponsiveness.
  • STING inhibitors represent a promising therapeutic strategy for severe asthma.
  • Nanoparticle delivery enhances the therapeutic efficacy of STING inhibitors for asthma treatment.